Atlas Trials

Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar Patients

Clinical trial NCT02466685 · COMPLETED

Trial details

NCT number
NCT02466685
Sponsor
Herbert Meltzer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bipolar Disorder
Start date
2015-09-01
Primary completion
2021-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.